| De novo lipogenesis in health and disease F Ameer, L Scandiuzzi, S Hasnain, H Kalbacher, N Zaidi Metabolism 63 (7), 895-902, 2014 | 622 | 2014 |
| ATP-citrate lyase: a key player in cancer metabolism N Zaidi, JV Swinnen, K Smans Cancer research 72 (15), 3709-3714, 2012 | 499 | 2012 |
| Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids N Zaidi, L Lupien, NB Kuemmerle, WB Kinlaw, JV Swinnen, K Smans Progress in lipid research 52 (4), 585-589, 2013 | 473 | 2013 |
| Lipid metabolism in cancer cells under metabolic stress R Munir, J Lisec, JV Swinnen, N Zaidi British journal of cancer 120 (12), 1090-1098, 2019 | 278 | 2019 |
| Cathepsin D: a cellular roadmap N Zaidi, A Maurer, S Nieke, H Kalbacher Biochemical and biophysical research communications 376 (1), 5-9, 2008 | 249 | 2008 |
| ATP-citrate lyase: a mini-review M Chypre, N Zaidi, K Smans Biochemical and biophysical research communications 422 (1), 1-4, 2012 | 224 | 2012 |
| ATP citrate lyase knockdown induces growth arrest and apoptosis through different cell-and environment-dependent mechanisms N Zaidi, I Royaux, JV Swinnen, K Smans Molecular cancer therapeutics 11 (9), 1925-1935, 2012 | 116 | 2012 |
| Cancer cells differentially activate and thrive on de novo lipid synthesis pathways in a low-lipid environment VW Daniëls, K Smans, I Royaux, M Chypre, JV Swinnen, N Zaidi PloS one 9 (9), e106913, 2014 | 115 | 2014 |
| Cathepsin E: a mini review N Zaidi, H Kalbacher Biochemical and biophysical research communications 367 (3), 517-522, 2008 | 82 | 2008 |
| COVID-19 severity: Studying the clinical and demographic risk factors for adverse outcomes N Shoaib, N Noureen, R Munir, FA Shah, N Ishtiaq, N Jamil, R Batool, ... PLoS One 16 (8), e0255999, 2021 | 51 | 2021 |
| A novel cell penetrating aspartic protease inhibitor blocks processing and presentation of tetanus toxoid more efficiently than pepstatin A N Zaidi, T Burster, V Sommandas, T Herrmann, BO Boehm, C Driessen, ... Biochemical and biophysical research communications 364 (2), 243-249, 2007 | 51 | 2007 |
| Anthropometric and metabolic indices in assessment of type and severity of dyslipidemia M Zaid, F Ameer, R Munir, R Rashid, N Farooq, S Hasnain, N Zaidi Journal of physiological anthropology 36, 1-10, 2017 | 50 | 2017 |
| Atypical plasma lipid profile in cancer patients: cause or consequence? R Munir, H Usman, S Hasnain, K Smans, H Kalbacher, N Zaidi Biochimie 102, 9-18, 2014 | 43 | 2014 |
| Emerging functional roles of cathepsin E N Zaidi, C Hermann, T Herrmann, H Kalbacher Biochemical and biophysical research communications 377 (2), 327-330, 2008 | 42 | 2008 |
| A new approach for distinguishing cathepsin E and D activity in antigen‐processing organelles N Zaidi, T Herrmann, D Baechle, S Schleicher, J Gogel, C Driessen, ... The FEBS journal 274 (12), 3138-3149, 2007 | 40 | 2007 |
| Too complex to fail? Targeting fatty acid metabolism for cancer therapy R Munir, J Lisec, JV Swinnen, N Zaidi Progress in lipid research 85, 101143, 2022 | 32 | 2022 |
| Cancer cell lipid class homeostasis is altered under nutrient-deprivation but stable under hypoxia J Lisec, C Jaeger, R Rashid, R Munir, N Zaidi BMC cancer 19, 1-11, 2019 | 30 | 2019 |
| Cathepsin E regulates the presentation of tetanus toxin C-fragment in PMA activated primary human B cells T Burster, M Reich, N Zaidi, W Voelter, BO Boehm, H Kalbacher Biochemical and biophysical research communications 377 (4), 1299-1303, 2008 | 24 | 2008 |
| Lipid metabolism F Ameer, R Munir, N Zaidi Reference Module in Biomedical Sciences 1 (1), 1-4, 2018 | 20 | 2018 |
| Revisiting the dyslipidemia associated with acute leukemia H Usman, R Rashid, F Ameer, A Iqbal, M Zaid, S Hasnain, H Kalbacher, ... Clinica Chimica Acta 444, 43-49, 2015 | 20 | 2015 |
